Family summary
Historical shortage references are available across related Ondansetron hydrochloride presentations from multiple manufacturers.
- 0 current shortage context pages.
- 6 historical shortage context pages.
- 4 manufacturers represented.
Ondansetron hydrochloride - Drug Shortage Information
Public shortage context is available across 6 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
ondansetron hydrochloride 2 mg / mL Injection 2 mL - NDC 25021-0777-02Sagent Pharmaceuticals | 25 VialOndansetron Hydrochloride 2 mg / mL Solution 2 mL - NDC 36000-0012-25Baxter Healthcare Corporation | 25 Vial, Single-DoseOndansetron Hydrochloride 2 mg / mL Injection 2 mL - NDC 55150-0125-02Eugia US LLC | 25 Vial, Single-DoseOndansetron Hydrochloride 2 mg / mL Injection 20 mL - NDC 55150-0126-20Eugia US LLC | 1 Vial, Multi-DoseOndansetron Hydrochloride 2 mg / mL Injection 2 mL - NDC 63323-0373-02Fresenius Kabi USA, LLC | 25 Vial
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.